With 510(k) clearance, platform streamlines OR and clinical access to imaging data
Sony Electronics' NUCLeUS(tm) Courtesy: Sony Electronics
By Whitney J. Palmer
Sony Electronics announced Wednesday that it received 510(k) clearance from the U.S. Food and Drug Administration for its NUCLeUS™ Operating Room, Imaging Management and Collaboration platform.
NUCLeUS is an open, vendor neutral video-over-IP platform that connects devices, applications, and data to facilitate surgical workflow. It connects to the PACS, hospital information system, operating room planning system, and DICOM worklists to, potentially, improve efficiency.
According to a company press release, NUCLeUS uses an existing network infrastructure to support up to 4K resolution and is designed to enhance and streamline workflow for operating rooms and clinical environments by providing direct imaging data access through a central dashboard. Via the system, providers can also capture and manage video and audio content in real-time.
“We are eager to put NUCLeUS in the hands of doctors, nurses, and OR managers in the [United States] so they can experience first-hand how the platform can dramatically improve surgical collaboration and potentially contribute to better outcomes,” said Theresa Alesso, president of Sony Electronics’ Pro divison in a press statement. “With the ongoing development of unique ‘smart applications,’ NUCLeUS will continue to push the boundaries of what is possible in the [operating room.]”
The system is already in use in more than 500 operating room venues in hospitals throughout Europe, including the United Kingdom, Belgium, and Sweden. Sales within the United States will begin immediately, according to the company.
Based on company information, important characteristics of NUCLeUS include:
MRI Long Covid Study Reveals Link Between Lower Pulmonary Gas Exchange and Cognitive Dysfunction
November 26th 2024For patients with Long Covid, lower pulmonary gas exchange may be associated with lower gray and white matter volume, according to new MRI research to be presented at the Radiological Society of North America (RSNA) conference.
New DEXA Scan Study Links Thyroid Medication Levothyroxine to Higher Bone Loss Risk in Seniors
November 25th 2024Use of the medication levothyroxine, commonly prescribed for hypothyroidism, was associated with greater long-term loss of total body bone mass in seniors, according to new DEXA research to be presented at the Radiological Society of North America (RSNA) conference.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.